Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | United States | $8.35B | 110,268,210 | 69.23% | 9.05% | Net Selling | Net Selling |
| ANTX | AN2 THERAPEUTICS INC | United States | $75.62M | 29,770,375 | 54.22% | 45.78% | Net Buying | |
| ADIL | ADIAL PHARMACEUTICALS INC | United States | $7.26M | 4,054,861 | 5.41% | 94.59% | Net Buying | |
| INSM | INSMED INC | United States | $3.81B | 148,491,583 | 79.99% | 20.01% | Net Buying | Net Buying |
| NKTR | NEKTAR THERAPEUTICS | United States | $306.64M | 183,617,817 | 64.89% | 14.15% | Net Selling | Net Selling |
| IKT | INHIBIKASE THERAPEUTICS INC | United States | $8.68M | 6,476,844 | 3.63% | 84.17% | ||
| NUVL | NUVALENT INC | United States | $4.64B | 64,067,638 | 70.74% | 29.26% | Net Selling | Net Selling |
| TCBP | TC BIOPHARM (HOLDINGS) PLC | United Kingdom | $4.63M | 63,902,641 | 0.12% | 11.35% | ||
| ABVX | ABIVAX SA | France | $938.90M | 62,928,818 | 33.79% | 0.00% | ||
| TCON | TRACON PHARMACEUTICALS INC | United States | $4.12M | 2,275,225 | 6.34% | 93.66% | Net Selling | |
| GRTS | GRITSTONE BIO INC | United States | $85.32M | 98,065,594 | 42.92% | 22.25% | Net Buying | |
| VALN | VALNEVA SE | $515.78M | 138,912,142 | 0.28% | 0.00% | |||
| AVTE | AEROVATE THERAPEUTICS INC | United States | $578.16M | 27,862,961 | 66.43% | 33.57% | Net Selling | Net Selling |
| TENX | TENAX THERAPEUTICS INC | United States | $7.42M | 1,958,245 | 7.69% | 92.31% | ||
| ABUS | ARBUTUS BIOPHARMA CORP | Canada | $505.76M | 188,717,409 | 24.75% | 75.25% | Net Selling | |
| LIPO | LIPELLA PHARMACEUTICALS INC | United States | $4.69M | 6,250,034 | 5.92% | 28.26% | Net Buying | Net Buying |
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | United States | $198.56M | 35,777,412 | 37.09% | 51.45% | Net Buying | |
| ACLX | ARCELLX INC | United States | $2.81B | 52,796,618 | 44.19% | 55.81% | Net Selling | Net Selling |
| ACRV | ACRIVON THERAPEUTICS INC | United States | $191.51M | 22,636,951 | 46.35% | 53.65% | Net Buying | Net Buying |
| CTXR | CITIUS PHARMACEUTICALS INC | United States | $112.48M | 159,094,781 | 16.86% | 7.74% | ||
| PYXS | PYXIS ONCOLOGY INC | United States | $256.37M | 58,133,375 | 15.13% | 36.17% | Net Selling | |
| CYTO | ALTAMIRA THERAPEUTICS LTD | Bermuda | $2.39M | 1,477,785 | 0.52% | 0.00% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | United States | $1.54B | 87,384,856 | 54.70% | 45.30% | Net Buying | Net Selling |
| RLAY | RELAY THERAPEUTICS INC | United States | $939.81M | 132,741,677 | 72.37% | 27.63% | Net Selling | Net Selling |
| JSPR | JASPER THERAPEUTICS INC | United States | $361.23M | 15,063,896 | 60.15% | 39.85% | Net Buying | Net Buying |
| VBIV | VBI VACCINES INC | United States | $16.58M | 28,432,275 | 3.92% | 96.08% | Net Buying | |
| ENTA | ENANTA PHARMACEUTICALS INC | United States | $294.28M | 21,155,983 | 58.46% | 41.54% | Net Selling | Net Selling |
| GLUE | MONTE ROSA THERAPEUTICS INC | United States | $280.86M | 50,154,073 | 24.82% | 75.18% | ||
| IONS | IONIS PHARMACEUTICALS INC | United States | $6.28B | 145,751,797 | 96.31% | 3.69% | Net Selling | Net Selling |
| NTRB | NUTRIBAND INC | United States | $40.04M | 10,969,870 | 1.78% | 51.68% | ||
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP | United States | $14.45M | 84,490,862 | 17.09% | 18.38% | ||
| LGVN | LONGEVERON INC | United States | $4.55M | 2,513,460 | 14.25% | 85.75% | Net Buying | Net Buying |
| MRSN | MERSANA THERAPEUTICS INC | United States | $407.58M | 121,303,007 | 42.94% | 57.06% | Net Selling | |
| ASND | ASCENDIS PHARMA A | Denmark | $8.22B | 58,224,419 | 100.00% | 0.00% | ||
| FNCH | FINCH THERAPEUTICS GROUP INC | United States | $4.00M | 1,605,763 | 1.07% | 98.93% | Net Selling | Net Selling |
| BTAI | BIOXCEL THERAPEUTICS INC | United States | $78.28M | 30,576,671 | 4.33% | 95.67% | Net Selling | Net Selling |
| CDMO | AVID BIOSERVICES INC | United States | $520.53M | 63,479,794 | 90.14% | 9.03% | Net Selling | Net Selling |
| MOR | MORPHOSYS AG | Germany | $2.69B | 37,655,137 | 63.38% | 0.00% | ||
| IOVA | IOVANCE BIOTHERAPEUTICS INC | United States | $3.60B | 279,307,043 | 16.06% | 83.94% | Net Buying | Net Buying |
| SEEL | SEELOS THERAPEUTICS INC | United States | $4.51M | 13,680,576 | 3.20% | 96.80% | Net Buying | Net Buying |
| GANX | GAIN THERAPEUTICS INC | United States | $47.52M | 16,219,709 | 9.53% | 2.11% | Net Buying | Net Buying |
| EYEN | EYENOVIA INC | United States | $44.40M | 47,386,349 | 24.06% | 27.52% | Net Buying | Net Buying |
| FENC | FENNEC PHARMACEUTICALS INC | United States | $246.34M | 27,099,908 | 4.18% | 95.82% | Net Buying | Net Selling |
| XNCR | XENCOR INC | United States | $1.44B | 61,120,272 | 66.74% | 33.26% | Net Buying | Net Selling |
| PYPD | POLYPID LTD | Israel | $7.94M | 1,653,559 | 1.27% | 0.00% | ||
| SGMO | SANGAMO THERAPEUTICS INC | United States | $93.39M | 178,906,350 | 48.59% | 17.99% | Net Selling | Net Selling |
| THAR | THARIMMUNE INC | United States | $4.44M | 11,739,676 | 1.16% | 37.18% | Net Buying | |
| APGE | APOGEE THERAPEUTICS INC | United States | $2.64B | 50,655,671 | 82.46% | 11.78% | Net Buying | |
| APM | APTORUM GROUP LTD | China | $28.03M | 5,181,697 | 0.85% | 40.28% | ||
| AZTR | AZITRA INC | United States | $6.34M | 28,804,643 | 0.16% | 55.13% | Net Buying | Net Buying |
| ALLK | ALLAKOS INC | United States | $96.66M | 87,873,995 | 46.03% | 53.97% | Net Selling | Net Selling |
| BCAB | BIOATLA INC | United States | $151.99M | 48,096,717 | 56.14% | 33.68% | Net Buying | Net Selling |
| APLT | APPLIED THERAPEUTICS INC | United States | $479.67M | 105,886,831 | 57.95% | 8.47% | Net Selling | Net Selling |
| CAPR | CAPRICOR THERAPEUTICS INC | United States | $164.53M | 31,399,667 | 11.23% | 88.77% | Net Buying | Net Buying |
| GTBP | GT BIOPHARMA INC | United States | $4.41M | 1,380,633 | 73.85% | 26.15% | Net Buying | |
| CMND | CLEARMIND MEDICINE INC | Canada (Federal Level) | $3.71M | 3,169,570 | 2.92% | 0.00% | ||
| CRIS | CURIS INC | United States | $97.31M | 5,894,085 | 3.46% | 96.54% | ||
| MBRX | MOLECULIN BIOTECH INC | United States | $11.47M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| CTNM | CONTINEUM THERAPEUTICS INC | United States | N/A | 27,055,790 | 0.00% | 9.96% | ||
| EDSA | EDESA BIOTECH INC | Canada | $14.45M | 3,171,760 | 1.29% | 98.71% | Net Buying | Net Buying |
| ELEV | ELEVATION ONCOLOGY INC | United States | $208.72M | 54,638,262 | 47.31% | 21.57% | Net Selling | Net Selling |
| ENLV | ENLIVEX THERAPEUTICS LTD | Israel | $30.13M | 18,598,555 | 1.01% | 77.27% | ||
| ENVB | ENVERIC BIOSCIENCES INC | United States | $6.75M | 7,294,005 | 6.71% | 5.99% | Net Buying | |
| GHRS | GH RESEARCH PLC | Ireland | $582.19M | 52,028,145 | 56.89% | 0.00% | ||
| HLVX | HILLEVAX INC | United States | $696.81M | 49,700,828 | 65.85% | 34.15% | Net Selling | Net Selling |
| OPT | OPTHEA LTD | Australia | $193.87M | 467,159,374 | 1.53% | 0.00% | ||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | United States | $3.56B | 82,335,687 | 83.47% | 16.53% | Net Selling | Net Selling |
| RVNC | REVANCE THERAPEUTICS INC | United States | $332.57M | 88,214,054 | 73.75% | 26.25% | Net Selling | Net Selling |
| SYRE | SPYRE THERAPEUTICS INC | United States | $1.31B | 36,150,941 | 52.09% | 47.91% | Net Buying | Net Buying |
| MGTX | MEIRAGTX HOLDINGS PLC | United States | $320.44M | 64,217,166 | 51.67% | 48.33% | Net Buying | |
| RPHM | RENEO PHARMACEUTICALS INC | United States | $57.82M | 33,420,808 | 61.78% | 38.22% | Net Buying | |
| MLYS | MINERALYS THERAPEUTICS INC | United States | $649.67M | 49,631,159 | 56.06% | 43.94% | Net Buying | Net Buying |
| TLSA | TIZIANA LIFE SCIENCES LTD | United Kingdom | $72.10M | 102,272,614 | 0.78% | 0.00% | ||
| TNYA | TENAYA THERAPEUTICS INC | United States | $362.74M | 78,516,142 | 55.16% | 44.84% | Net Buying | Net Buying |
| SLDB | SOLID BIOSCIENCES INC | United States | $386.25M | 37,756,877 | 21.64% | 78.36% | Net Buying | |
| TSHA | TAYSHA GENE THERAPIES INC | United States | $482.51M | 187,018,275 | 69.58% | 15.93% | Net Buying | |
| PEPG | PEPGEN INC | United States | $468.82M | 32,354,495 | 50.08% | 18.34% | Net Buying | Net Buying |
| ONCY | ONCOLYTICS BIOTECH INC | Canada | $87.08M | 74,423,960 | 6.91% | 0.00% | ||
| VIRI | VIRIOS THERAPEUTICS INC | United States | $8.11M | 19,257,937 | 4.47% | 5.34% | Net Buying | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $32.99M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| VTYX | VENTYX BIOSCIENCES INC | United States | $290.93M | 59,252,349 | 39.06% | 60.94% | Net Selling | Net Selling |
| XFOR | X4 PHARMACEUTICALS INC | United States | $181.37M | 167,937,781 | 57.63% | 1.30% | Net Selling | Net Selling |
| PHVS | PHARVARIS NV | Netherlands | $1.23B | 52,290,212 | 77.92% | 0.00% | ||
| DYN | DYNE THERAPEUTICS INC | United States | $2.27B | 87,382,638 | 65.80% | 34.20% | Net Selling | Net Selling |
| GNTA | GENENTA SCIENCE SPA | Italy | $60.30M | 18,216,958 | 2.53% | 0.00% | ||
| BLTE | BELITE BIO INC | United States | $1.20B | 29,149,444 | 0.53% | 0.00% | ||
| IMMX | IMMIX BIOPHARMA INC | United States | $60.98M | 26,396,420 | 2.96% | 31.19% | Net Buying | |
| GLSI | GREENWICH LIFESCIENCES INC | United States | $180.17M | 12,878,409 | 4.02% | 95.98% | Net Buying | Net Buying |
| BMEA | BIOMEA FUSION INC | United States | $428.82M | 35,944,584 | 61.83% | 38.17% | Net Selling | |
| PDSB | PDS BIOTECHNOLOGY CORP | United States | $136.81M | 36,679,275 | 22.71% | 31.97% | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $10.44M | 284,094,700 | 0.99% | 5.96% | ||
| CYCC | CYCLACEL PHARMACEUTICALS INC | United States | $3.28M | 1,318,257 | 1.23% | 98.77% | Net Buying | |
| CDXS | CODEXIS INC | United States | $235.66M | 70,557,577 | 46.84% | 53.16% | Net Buying | |
| GNPX | GENPREX INC | United States | $4.51M | 1,910,441 | 48.09% | 51.91% | Net Selling | Net Selling |
| KPTI | KARYOPHARM THERAPEUTICS INC | United States | $124.27M | 115,067,083 | 63.84% | 32.73% | Net Selling | Net Selling |
| RLYB | RALLYBIO CORP | United States | $69.20M | 37,811,970 | 43.27% | 56.73% | ||
| SLN | SILENCE THERAPEUTICS PLC | United Kingdom | $842.97M | 118,846,966 | 17.28% | 0.00% | ||
| SLRX | SALARIUS PHARMACEUTICALS INC | United States | $2.28M | 4,314,433 | 2.20% | 97.80% | ||
| CGTX | COGNITION THERAPEUTICS INC | United States | $77.22M | 39,000,152 | 18.34% | 62.09% | Net Buying | Net Buying |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $52.82M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.